PMV Pharmaceuticals, Inc. appointed Laurie Stelzer to the Board of Directors as Audit Committee chair. Stelzer currently serves as Chief Financial Officer of Arena Pharmaceuticals, a clinical-stage biotechnology company. Prior to joining Arena, she was the Chief Financial Officer of Halozyme, leading the Finance, Information Technology, Business Development, Project Management and Site Operations organizations. Prior to joining Halozyme, Stelzer held senior management roles at Shire Plc (acquired by Takeda), including Senior Vice President of Finance, Division CFO for the Regenerative Medicine Division, and Head of Investor Relations. Previously she held positions of increasing responsibility during her 15 year career at Amgen, Inc., spanning the areas of Finance, Treasury, Global Accounting and International/Emerging Markets.